Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Xcyte Digital Corp. Signs Agreement to Purchase Assets of Webinar.net (click to learn more) Viva Gold Reports Multiple High-Grade Gold Hits at the Tonopah Gold Project (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

VentriPoint Diagnostics Ltd V.VPT

Alternate Symbol(s):  VPTDF

Healthcare Medical Devices
Ventripoint Diagnostics Ltd is a Canada-based medical device company. The Company is engaged in the development and commercialization of diagnostic tools that monitor patients with heart disease. It is developing a suite of applications for all heart diseases and imaging modalities, including congenital heart disease, pregnancy, pulmonary hypertension, COVID-19, imaging, and cardiotoxicity in oncology patients. The Company’s Ventripoint Medical System (VMS+) is a diagnostic aid that was developed to provide a point-of-care solution to better communicate the heart’s structure and function without the need for magnetic resonance imaging (MRI). VMS+ enhances ultrasound, providing three-dimensional (3D) technology that allows for visualization of all four chambers of the heart. The system’s proprietary Knowledge Based Reconstruction (KBR) technology creates 3D models of the heart and calculates volumes and ejection fractions equivalent to the gold-standard Magnetic resonance imaging (MRI).


TSXV:VPT - Post by User

VentriPoint Diagnostics Ltd > good new ."Dear Friend;
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(91)
•••
Comment by jopatcloon Apr 11, 2024 12:32pm
45 Views
Post# 35983576

RE:good new ."Dear Friend;

RE:good new ."Dear Friend;good now 0.244 good comment 
12:30 R 0,24  0,025 0,225 0,24 4 000 / 42 500 109,50k 0,24 0,21
@cardinal .25 off market convertible
 
12
 
@sebidre let's wait and see if it gets filled..
 
0
 
@Razor If gets filled? I'm thinking opposite - might increase.
 
7
 
@Razor  above message is totally bullish. Favorable terms for both investors & shareholders. Win-win.
 
11
 
@cardinal They have plenty of interest. Sales are imminent as well. Should get Ventripoint through to sale
 
12
 
@TonyTwoShoes well at least theres a target price by late october 2026
 
0
 
@cardinal why do you think that they can only sell 4.0? you realize as they have stated that they are moving through the sales process with 100s of clients. Imminent because the CEO says so and he is rock solid! 3.2 is game changing tech. For instance it has massively decreased the need for Ped MRI at Toronto childrens. This is why Luc Mertens joined the advisory for free. They will sell plenty of 3.2 with upgrade agreements.
 
13
 
@cardinal Hope to see a few this month. and strong interest this quarter.
 
7
 
@cardinal don't know the exact numbers but pretty sure they are burning far less than that
 
8
 
@cardinal noi am not
 
2
 
@cardinal They are doing a quarter of the conferences this year. Those were costing hundreds of thousands. they spent huge on 4.0 which is now done. I believe according tho Hugh they have reduced burn now
 
9
 
@cardinal There is other R and D happening that could double or more this companies market. Those studies will be paid by others
 
6
 
@cardinal I asked recently and I think he said they have over a half mil still. They have made a few sales as well
 
9
 
@Lumberjumbo Hopefully time now for some nice news releases. Feels like it’s been a long time.
 
10
 
@yudi Yes we are due for some good news from Bart...I think India! Japan! and Europe before that of the US -11. Closing the sale of a VMS+3.2 system to a top 10 U.S. cardiology center;
 
3
 
@Anima Lots of confidence in this deal. Great to see.
 
11
 
@cardinal More insider buying
 
4

@yudi  whinersPatiencePays 15 cents should arrive shortly MDR now .24 Unexpectedly one day Dr.G.Adams will surprise the players with their pants around their ankles...at this stage of the game.Go Ventripoint for Sales worldwide...$$$ gang of children FUDSTERS to frustrate Ventripoint guess who they are? these are talking among themselves for an agenda to denigrate Ventripoint here and on SH .
@cardinal .25 off market convertible
 
12
 
@sebidre let's wait and see if it gets filled..
 
0
 
@Razor If gets filled? I'm thinking opposite - might increase.
 
7
 
@Razor  above message is totally bullish. Favorable terms for both investors & shareholders. Win-win.
 
11
 
@cardinal They have plenty of interest. Sales are imminent as well. Should get Ventripoint through to sale
 
12
 
@TonyTwoShoes well at least theres a target price by late october 2026
 
0
 
@cardinal why do you think that they can only sell 4.0? you realize as they have stated that they are moving through the sales process with 100s of clients. Imminent because the CEO says so and he is rock solid! 3.2 is game changing tech. For instance it has massively decreased the need for Ped MRI at Toronto childrens. This is why Luc Mertens joined the advisory for free. They will sell plenty of 3.2 with upgrade agreements.
 
13
 
@cardinal Hope to see a few this month. and strong interest this quarter.
 
7
 
@cardinal don't know the exact numbers but pretty sure they are burning far less than that
 
8
 
@cardinal noi am not
 
2
 
@cardinal They are doing a quarter of the conferences this year. Those were costing hundreds of thousands. they spent huge on 4.0 which is now done. I believe according tho Hugh they have reduced burn now
 
9
 
@cardinal There is other R and D happening that could double or more this companies market. Those studies will be paid by others
 
6
 
@cardinal I asked recently and I think he said they have over a half mil still. They have made a few sales as well
 
9
 
@Lumberjumbo Hopefully time now for some nice news releases. Feels like it’s been a long time.
 
10
 
@yudi Yes we are due for some good news from Bart...I think India! Japan! and Europe before that of the US -11. Closing the sale of a VMS+3.2 system to a top 10 U.S. cardiology center;
 
3
 
@Anima Lots of confidence in this deal. Great to see.
 
11
 
@cardinal More insider buying
 
4

<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities